drugset / Trial / NCT05529849

A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects

NCT05529849 ↗

Phase 1 Completed 76 enrolled Endevica Bio
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will test an experimental drug named TCMCB07 for the treatment of cancer cachexia. Cachexia is a syndrome characterized by weight loss, anorexia, weakness or lack of energy, and anemia. Cachexia occurs in many cancers, usually at the advanced stages of disease.

Timeline

Start
2022-07-12
Primary completion
2022-12-12
Completion
2023-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject TCMCB07 Unknown — Subcutaneous